(1) Our study "Patient-specific signaling signatures predict optimal therapeutic combinations for triple negative breast cancer" was published in Molecular Cancer
Great effort by teams from @MayoClinic and Hadassah, the White @MIT and @BalalashLab teams
https://t.co/rMA2MqiKw8
Delighted to share our review: "The Immunogenic Radiation & New Players in Immunotherapy and Targeted Therapy for Head & Neck Cancer”
I want to thank my fellow scientists, @BalashaLab, Dr Michael Gough & our wonderful students @narmeen_daher & Deema Zaid
https://t.co/AWjifXb1Sw
Congratulations Hadas Solgi and
@zaid_deema for receiving a white coat! Although this wonderful ceremony marks the transition from the study of preclinical to clinical sciences - Hadas and Deema take a break from clinical studies to obtain MSc and PhD degrees! Proud of you! 🎉🎉
Such a great way to start 2022! Congratulations @MariaJubran , the leading author of our newly published paper “Overcoming resistance to EGFR monotherapy in HNSCC by identification and inhibition of individualized cancer processes” and the team ! https://t.co/qrZwfFMpEN